Robinhood vs. AMC: Tenev Draws the Line on Tokenized Stocks
Vlad Tenev says issuers shouldn't be able to veto tokenized stock products that don't change shareholder rights or the official ledger. AMC's Adam Aron disagrees. The fight is really about who controls how retail gets exposure to public equity.
Vlad Tenev just drew the cleanest line anyone's drawn in the tokenized equity debate, and AMC's Adam Aron walked straight into it. The Robinhood CEO says public companies shouldn't get veto power over tokenized products that don't touch shareholder rights, issuer obligations, or the official shareholder ledger. Frankly, that's the correct framework. If a wrapper doesn't change the cap table, the issuer doesn't own the decision.
What Tenev Actually Said
The comments went up on X, and they read like a quiet roadmap for how Robinhood plans to defend this business. Three things a tokenized product can't do, per Tenev. It can't change shareholder rights, can't change what the issuer owes, and can't change the official ledger. If it does none of those, he argues, the issuer has no standing to block it.
That's a narrow claim. And it's a smart one.
Robinhood rolled out tokenized US stocks and ETFs in the EU in late June, roughly 200 tickers built on Arbitrum, available to European users. AMC was on the list. Aron fired back fast, arguing the tokens aren't AMC shares and carry no voting rights, no dividends, and no direct claim on the company. He's not wrong on the mechanics.
Here's what matters: the tokens are a claim on Robinhood's custody arrangement, not on AMC's equity.
That distinction is doing a lot of work, and Robinhood hasn't been loud enough about it.
The numbers tell the story on why this matters to HOOD holders. Robinhood's stock has nearly tripled this year, and crypto plus prediction markets are a real part of that re-rating. Tokenized equities are the next leg of the thesis. If issuers can veto at will, the product line dies in the crib. So Tenev's post isn't philosophy. It's positioning.
Where Aron Has a Real Point
Counterparty risk. That's the steelman.
A European user buying a tokenized AMC share isn't buying AMC. They're buying Robinhood's promise that a share sits somewhere in a custody account backing the token. If Robinhood fails, or the custody chain breaks, the token holder is in line behind a lot of other creditors. Aron's real worry, and it's a fair one, is that retail won't read past the ticker.
There's also governance. AMC's shareholder base is unusually retail-heavy, and those holders vote. Token holders don't. Aron is protecting the one thing he actually controls, which is the integrity of his cap table and the attention of his investors.
But that's a disclosure problem, not a veto problem.
If the token holds the same economic exposure and zero governance, is it a security, a derivative, or a receipt? That question needs an answer, and it shouldn't come from a CEO who happens to run the underlying company.
The Verdict
Tenev wins this round. Issuers shouldn't control how third parties package exposure to their stock, just like they don't control options, swaps, or ADRs. But Robinhood owes the market cleaner language. Label the tokens as receipts. Disclose the custody chain. Say out loud that there's no vote.
Do that, and the AMC objection collapses into a footnote.
What to watch: whether Robinhood adds voting rights to the token wrapper, whether other issuers follow Aron's playbook, and whether US regulators take a view before a domestic launch. On risk, the regulatory question is the one that actually moves the stock. The AMC spat is noise. The structure is the signal.
